<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(12)</volume><submitter>Li B</submitter><journal>Blood cancer journal</journal><pagination>e505</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5223151</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Bone marrow fibrosis grade is an independent risk factor for overall survival in patients with primary myelofibrosis.</pubmed_title><pmcid>PMC5223151</pmcid><pubmed_authors>Sha Z</pubmed_authors><pubmed_authors>Huang G</pubmed_authors><pubmed_authors>Xiao Z</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Feng G</pubmed_authors><pubmed_authors>Qin T</pubmed_authors><pubmed_authors>Zhang P</pubmed_authors><pubmed_authors>Dong D</pubmed_authors><pubmed_authors>Qu S</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Hu N</pubmed_authors><pubmed_authors>Li B</pubmed_authors><pubmed_authors>Pan L</pubmed_authors><pubmed_authors>Fang L</pubmed_authors><pubmed_authors>Xu Z</pubmed_authors><pubmed_authors>Cai W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bone marrow fibrosis grade is an independent risk factor for overall survival in patients with primary myelofibrosis.</name><description/><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Dec</publication><modification>2025-04-22T19:26:05.808Z</modification><creation>2025-04-06T02:43:57.073Z</creation></dates><accession>S-EPMC5223151</accession><cross_references><pubmed>27935577</pubmed><doi>10.1038/bcj.2016.116</doi></cross_references></HashMap>